Multimodal DNA And RNA Library Kit Advances Efficiency In Multiomic NGS For Precision Medicine Is Affecting The Direction Of The Next-Generation Sequencing (NGS) In Precision Medicine Market
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The Next-Generation Sequencing (NGS) In Precision Medicine Market Progress Through 2030?
The next-generation sequencing (ngs) in precision medicine market size has experienced rapid growth over recent years. Forecasts indicate it will expand from $6.42 billion in 2025 to $7.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 17.2%. This market’s past growth is primarily linked to the progression of high-throughput sequencers, increasing recognition of personalized medicine, expansion in genomic research, broader availability of bioinformatics software, and the incorporation of precision medicine into clinical trials.
The market size for next-generation sequencing (ngs) in precision medicine is anticipated to show significant expansion over the next few years. It is projected to reach $14.05 billion by 2030, achieving this with a compound annual growth rate (CAGR) of 16.9%. The projected increase in the forecast period can be linked to improvements in sequencing instrument technology, the integration of AI within genomics, an increase in cloud-based sequencing services, growing collaborations among pharmaceutical and biotech companies, and the spread of precision medicine into developing regions. Prominent trends expected during the forecast period include AI-driven genomic analysis, cloud-based sequencing solutions, the broadening reach of personalized medicine, greater automation in sequencing workflows, and real-time interpretation of genomic data.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28280&type=smp
What Influential Factors Are Boosting The Next-Generation Sequencing (NGS) In Precision Medicine Market Demand?
An increase in genetic disorders is projected to boost the expansion of the next-generation sequencing (NGS) in precision medicine market in the coming years. Genetic disorders are defined as illnesses or states resulting from irregularities in an individual’s DNA, which may be passed down or arise from mutations. The frequency of genetic disorders is increasing because progress in diagnostic tools, like genetic screening and next-generation sequencing, enables medical professionals to detect cases previously overlooked, consequently showing a greater reported prevalence. Next-generation sequencing in precision medicine facilitates the identification of genetic mutations, thereby allowing for precise diagnosis, tailored treatment, and prompt intervention for genetic disorders. For example, as reported by the National Health Service, a UK-based government department, in May 2024, roughly 17,000 individuals in England suffer from sickle cell disease, an inherited blood condition, with approximately 250 new diagnoses annually. Consequently, the growing occurrence of genetic disorders is fueling the expansion of the next-generation sequencing (NGS) in precision medicine market.
What Are The Core Segment Classifications In The Next-Generation Sequencing (NGS) In Precision Medicine Market?
The next-generation sequencing (ngs) in precision medicine market covered in this report is segmented –
1) By Product And Service: Sequencing Instruments, Consumables And Reagents, Library Preparation Kits, Bioinformatics Software, Next-Generation Sequencing (NGS) Services
2) By Technology: Whole Genome Sequencing (WGS), Whole Exome Sequencing (Wes), Targeted Sequencing, Ribonucleic Acid (RNA) Sequencing, Single-Cell Sequencing
3) By Application: Oncology, Infectious Disease, Rare And Inherited Disorders, Prenatal And Reproductive Health, Pharmacogenomics
4) By End Use: Hospitals And Clinics, Academic And Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)
Subsegments:
1) By Sequencing Instruments: Benchtop Sequencers, High Throughput Sequencers
2) By Consumables And Reagents: Sequencing Reagents, Sequencing Chips, Flow Cells, Sample Preparation Reagents
3) By Library Preparation Kits: Deoxyribonucleic Acid (DNA) Library Preparation Kits, Ribonucleic Acid (RNA) Library Preparation Kits, Whole Genome Amplification Kits, Target Enrichment Kits
4) By Bioinformatics Software: Data Analysis Software, Data Management Software, Sequence Alignment Software, Variant Calling Software
5) By Next-Generation Sequencing Services: Whole Genome Sequencing Services, Whole Exome Sequencing Services, Targeted Sequencing Services, Ribonucleic Acid (RNA) Sequencing Services, Epigenomic Sequencing Services
Which Trends Are Shaping The Next-Generation Sequencing (NGS) In Precision Medicine Market Landscape?
Leading firms within the next-generation sequencing (NGS) in precision medicine market are concentrating on creating novel solutions, like multimodal DNA and RNA library kits, to improve the effectiveness and precision of genomic analyses. Such a kit is a laboratory tool designed to prepare sequencing libraries from both DNA and RNA concurrently within a single process, thereby allowing a thorough examination of a sample’s genome and transcriptome. An example of this is Qiagen N.V., a German company specializing in molecular diagnostics sample and assay technologies, which introduced its QIAseq Multimodal DNA and RNA Library Kit in May 2024. This next-generation sequencing offering promotes multiomic research and contributes to precision medicine by simplifying DNA and RNA library preparation from just one sample. The kit supports sequencing of both the entire genome and transcriptome, alongside subsequent target enrichment, aiding multiomic studies through its optimized chemistry that processes DNA and RNA at the same time. It also lessens the requirement for significant sample quantities and the laborious methods typically associated with separate DNA and RNA preparation workflows. By boosting the efficiency of multiomic investigations, this solution propels precision medicine forward by facilitating improved biomarker identification and a deeper comprehension of diseases, especially in the field of cancer research.
Who Are The Firms Contributing To The Next-Generation Sequencing (NGS) In Precision Medicine Market Ecosystem?
Major companies operating in the next-generation sequencing (ngs) in precision medicine market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Natera Inc., Tempus Labs Inc., 10x Genomics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Fulgent Genetics Inc., Twist Bioscience Corporation, Pacific Biosciences of California Inc., Macrogen Inc., Ultima Genomics Inc., Personalis Inc., Element Biosciences Inc., Genomenon Inc., Strand Life Sciences Pvt. Ltd., Singular Genomics Systems Inc.
Access The Complete Next-Generation Sequencing (NGS) In Precision Medicine Market Report:
Which Region Holds The Largest Share In The Next-Generation Sequencing (NGS) In Precision Medicine Market?
North America was the largest region in the next-generation sequencing (NGS) in precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs) in precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Next-Generation Sequencing (NGS) In Precision Medicine Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Next-Generation Sequencing (NGS) In Precision Medicine Market 2026, By The Business Research Company
Ngs Based Rna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Clinical Oncology Next Generation Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
